REPORT SCOPE & OVERVIEW
Nebulizer Market was estimated at USD 1.08 billion in 2022 and is poised to reach at 1.72 billion in 2030 anticipated to expand at a compound annual growth rate approx. CAGR of 6% for the forecast period of 2023-2030.
The rapid rise is linked to the rising prevalence of chronic respiratory disorders, the expanding need for home medical equipment, and the growing elderly population. Chronic obstructive pulmonary disease (COPD), according to the Centres for Disease Control and Prevention, is the fourth most common cause of mortality in the United States. In addition, a significant factor contributing to the rise in the prevalence of respiratory disorders in North America is the increased intake of alcohol, cigarettes, and ultra-processed goods, particularly drinks with added sugar. According to data from the Centres for Disease Control and Prevention (CDC), tobacco use accounts for around 14% of fatalities among adults in North America between the ages of 30 and 70. Therefore, it is projected that a rise in smoking rates and environmental pollutants will raise the demand for Nebulizer Market. Nebulizer and respiratory device markets are fairly developed, with jets dominating due to their low price. As a result, fierce competition is anticipated for additional nebulization devices. Additionally, it is difficult for new technologies or devices to take off in developed markets, especially given the complexity of several national regulatory and reimbursement systems that must be adhered to for both medications and devices. Additionally, it is difficult for new technologies or devices to take off in developed markets, especially given the complexity of several national regulatory and reimbursement systems that must be adhered to for both medications and devices. Due to the greater number of tolerances, components, important parts, and assemblies connected to both mesh and electronic control circuits, mesh nebulizers are more costly than jet nebulizers. In addition, big corporations including Philips, Vectura, and Pari Gmbh have been using mesh nebulizers more often in clinical studies since 2006, which is anticipated to accelerate market expansion in the next years.
Rising Respiratory Disease Prevalence & ageing population growth.
Homecare settings and technological advancements: self-administration.
One of the main factors driving the nebulizer market is the increasing prevalence of chronic respiratory disorders including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. In the management and treatment of these disorders, nebulizers are frequently employed. The prevalence of respiratory disorders is rising, especially among the elderly, as the world's population continues to age. Nebulizer demand is fueled by the senior population's need for efficient respiratory medicine delivery systems. Nebulizer technological advancements, such as portable and ultrasonic nebulizers, have enhanced convenience, simplicity of usage, and therapeutic results.
Alternatives are available & Nebulizer Devices are costly.
Drug Compatibility Restrictions.
Metered-dose inhalers (MDIs) and dry powder inhalers (DPIs) can be used to deliver respiratory drugs instead of nebulizers. The market for nebulizers faces competition from inhalers because they are more portable, require less time for administration, and may deliver drugs more effectively. Some nebulizer devices can be costly, which restricts their accessibility, especially in underdeveloped countries with limited resources. Nebulizer adoption may be hampered by their high price, particularly in areas where pricing matters. Due to stability or compatibility difficulties, some drugs may not be appropriate for nebulizer delivery. This restriction may limit the variety of medications that may be administered using nebulizers, which may have an impact on market potential.
The desire for home-based treatment and self-administration of drugs is on the rise, which creates the potential for nebulizer producers.
Homecare nebulizers provide comfort, simplicity, and increased patient compliance.
For makers of nebulizers, emerging markets, notably those in Asia-Pacific and Latin America, present considerable growth prospects. The market is expanding as a result of growing healthcare infrastructure, increased awareness of respiratory disorders, and rising disposable incomes. Nebulizers are frequently used to provide drugs to kids with respiratory disorders in paediatric settings. Since paediatric patients frequently need specialised nebulizer devices and kid-friendly designs, the paediatric sector provides a significant market potential.
Stringent Regulatory Requirements & Cleaning and infection control issues.
Manufacturers of nebulizers face difficulties in complying with regulations, notably those relating to safety, performance, and quality requirements. Regulation compliance may be time- and money-consuming.
Nebulizers need to be cleaned and maintained on a regular basis to reduce contamination and the risk of infection. It might be difficult to ensure correct cleaning procedures and patient education on cleanliness, particularly in homecare settings. The cost and availability of nebulizer devices may be impacted by variations in reimbursement practises among various geographic areas and healthcare systems. Market expansion may be hampered by inadequate reimbursement coverage or reimbursement delays.
IMPACT OF RUSSIAN UKRAINE WAR
Air pollution is the main environmental and health hazard. Patients with asthma who cannot even take a breath there are directly damaged by the high levels of air pollutants brought on by the use of conventional weapons and the fires started by fighting, which includes poisonous gases, heavy metals, and particulate matter (PM). The health care system of Ukraine is functioning at a reduced capacity. On the one hand, the continuous attacks of Russian forces on Ukrainian hospitals and other health facilities increased the prevalence of diseases more than 4 million people had to flee Ukraine as of today, including health professionals, these people were left in need of shelter to escape the vicious attacks and also asthma patient affected more because they not even get the Nebulizer machines to survive in that situation and breath to alive. More details are comprised in the final report.
IMPACT OF ONGOING RECESSION
In the United States, the market for nebulizers is anticipated to reach US$327 million in 2022. The second-largest economy in the world, China, is anticipated to grow at a 7.6% CAGR from 2022 to 2030 to reach a projected market size of US$399.4 million. Japan and Canada are two more notable regional markets, with growth rates of 2.8% and 4.6%, respectively, expected between 2022 and 2030. Germany is anticipated to expand within Europe at a rate of about 4% CAGR. Several important causes, such as rising consumer demand, technological improvements, and altering customer tastes, are driving this rise.
KEY MARKET SEGMENTS
Hospitals And Clinics
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of the Middle East & Africa
Rest of Latin American
Due to rising respiratory illnesses and government initiatives such favourable reimbursement situations, more consumer awareness, and a solid healthcare infrastructure, North America held over 30% of the global nebulizer market in 2022. In addition, favourable reimbursement policies and the launch of technologically improved gadgets are anticipated to support market expansion in this area. Additionally, the U.S.'s growing senior population is driving an increase in surgeries nationwide, which is fueling the expansion of the local market. For instance, during the next 40 years, the number of Americans 65 and older will more than quadruple, reaching 80 million in 2040.
Due to its high senior population, increased emphasis on preventative care, and government efforts supporting technology advancements, the Asia Pacific region is anticipated to see the fastest market growth throughout the forecast period. The demand for these gadgets has been fueled by the region's rising healthcare costs and rising patient awareness. Foreign firms have been successfully drawn to this market by the region's governments' advantageous tax laws and low-cost manufacturing facilities. Additionally, the expansion of medical tourism in nations like India, the Philippines, Malaysia, and Singapore has contributed to the expansion of the entire area.
The major key players are Omron Corporation, GE Healthcare, Koninklijke Philips N.V., Aire Healthcare, Vectura Group Plc., PARI Respiratory Equipment, Inc., AerogenDeVilbiss Healthcare LLC, Briggs Healthcare, PARI Pharma GmBH and others.
Omron Corporation-Company Financial Analysis
PARI Pharma GmBH:
The LAMIRA nebulizer system was given permission to distribute ARIKAYCE (amikacin liposome inhalation solution) in Japan in March 2021. The device has a customised drug reservoir with an 8.4 ml dosage capacity and a specially designed aerosol head with a valved aerosol chamber for the aerosolization of ARIKAYCE.
In March 2021, Aire Health and LucidAct Inc. worked together to connect the LucidAct provider portal with their digital health platform in order to offer remote management of chronic respiratory conditions including chronic obstructive pulmonary disease (COPD) and other respiratory conditions.
|Market Size in 2022||US$ 1.08 Bn|
|Market Size by 2030||US$ 1.72 Bn|
|CAGR||CAGR of 6% From 2023 to 2030|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Type (Jet, Mesh, Ultrasonic)
• By Application (COPD, Cystic Fibrosis, Asthma, Others)
• By End-use (Hospitals & Clinics, Emergency Centers, Home Healthcare)
|Regional Analysis/Coverage||North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Company Profiles||Omron Corporation, GE Healthcare, Koninklijke Philips N.V., Aire Healthcare, Vectura Group Plc., PARI Respiratory Equipment, Inc., AerogenDeVilbiss Healthcare LLC, Briggs Healthcare, PARI Pharma GmBH|
|Key Drivers||• Rising Respiratory Disease Prevalence & ageing population growth.
• Homecare settings and technological advancements: self-administration.
|Market Opportunities||• The desire for home-based treatment and self-administration of drugs is on the rise, which creates the potential for nebulizer producers.
• Homecare nebulizers provide comfort, simplicity, and increased patient compliance.
Ans: The CAGR Growth rate of Nebulizer Market is approx. CAGR 6 % for the forecast period of 2023-2030.
Ans: The projected market size of Nebulizer Market at USD 1.08 billion in 2022 and is poised to reach at 1.72 billion in 2030.
Ans: The major key players are Omron Corporation, GE Healthcare, Koninklijke Philips N.V., Aire Healthcare, Vectura Group Plc., PARI Respiratory Equipment, Inc., AerogenDeVilbiss Healthcare LLC, Briggs Healthcare, PARI Pharma GmBH and others.
Ans: Growth in the nebulizer market is primarily being driven by factors such as the increased prevalence of chronic respiratory disorders, rising demand for home healthcare equipment, and an ageing population.
Ans: In 2022, North America held over 30% of the global nebulizer market thanks to rising respiratory illnesses and government initiatives such favourable reimbursement situations, more consumer awareness, and a strong healthcare system.
Table of Contents
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 Impact of the Ukraine- Russia war
4.2 Impact of ongoing Recession
4.2.2 Impact on major economies
184.108.40.206 United Kingdom
220.127.116.11 South Korea
18.104.22.168 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Nebulizer Market, By Type.
9. Nebulizer Market, By Application
9.2 Cystic Fibrosis
10. Nebulizer Market, By End-User
10.1 Hospitals And Clinics
10.2 Emergency Centers
10.3 Home Healthcare
11. Regional Analysis
11.2 North America
11.2.1 North America Nebulizer Market by country
11.2.2North America Nebulizer Market by Type
11.2.3 North America Nebulizer Market by Application
11.2.4 North America Nebulizer Market by End-User
22.214.171.124 USA Nebulizer Market by Type
126.96.36.199 USA Nebulizer Market by Application
188.8.131.52 USA Nebulizer Market by End-User
184.108.40.206 Canada Nebulizer Market by Type
220.127.116.11 Canada Nebulizer Market by Application
18.104.22.168 Canada Nebulizer Market by End-User
22.214.171.124 Mexico Nebulizer Market by Type
126.96.36.199 Mexico Nebulizer Market by Application
188.8.131.52 Mexico Nebulizer Market by End-User
11.8.1 Europe Nebulizer Market by country
11.8.2 Europe Nebulizer Market by Type
11.8.3 Europe Nebulizer Market by Application
11.8.4 Europe Nebulizer Market by End-User
184.108.40.206 Germany Nebulizer Market by Type
220.127.116.11 Germany Nebulizer Market by Application
18.104.22.168 Germany Nebulizer Market by End-User
22.214.171.124 UK Nebulizer Market by Type
126.96.36.199 UK Nebulizer Market by Application
188.8.131.52 UK Nebulizer Market by End-User
184.108.40.206 France Nebulizer Market by Type
220.127.116.11 France Nebulizer Market by Application
18.104.22.168 France Nebulizer Market by End-User
22.214.171.124 Italy Nebulizer Market by Type
126.96.36.199 Italy Nebulizer Market by Application
188.8.131.52 Italy Nebulizer Market by End-User
184.108.40.206 Spain Nebulizer Market by Type
220.127.116.11 Spain Nebulizer Market by Application
18.104.22.168 Spain Nebulizer Market by End-User
11.3.11 The Netherlands
22.214.171.124 Netherlands Nebulizer Market by Type
126.96.36.199 Netherlands Nebulizer Market by Application
188.8.131.52 Netherlands Nebulizer Market by End-User
11.3.11 Rest of Europe
184.108.40.206 Rest of Europe Nebulizer Market by Type
220.127.116.11 Rest of Europe Nebulizer Market by Application
18.104.22.168 Rest of Europe Nebulizer Market by End-User
11.4.1 Asia Pacific Nebulizer Market by country
11.4.2 Asia Pacific Nebulizer Market by Type
11.4.3 Asia Pacific Nebulizer Market by Application
11.4.4Asia Pacific Nebulizer Market by End-User
22.214.171.124 Japan Nebulizer Market by Type
126.96.36.199 Japan Nebulizer Market by Application
188.8.131.52 Japan Nebulizer Market by End-User
11.4.7 South Korea
184.108.40.206 South Korea Nebulizer Market by Type
220.127.116.11 South Korea Nebulizer Market by Application
18.104.22.168 South Korea Nebulizer Market by End-User
22.214.171.124 China Nebulizer Market by Type
126.96.36.199 China Nebulizer Market by Application
188.8.131.52 China Nebulizer Market by End-User
184.108.40.206 India Nebulizer Market by Type
220.127.116.11 India Nebulizer Market by Application
18.104.22.168 India Nebulizer Market by End-User
22.214.171.124 Australia Nebulizer Market by Type
126.96.36.199 Australia Nebulizer Market by Application
188.8.131.52 Australia Nebulizer Market by End-User
11.4.11 Rest of Asia-Pacific
184.108.40.206 APAC Nebulizer Market by Type
220.127.116.11 APAC Nebulizer Market by Application
18.104.22.168 APAC Nebulizer Market by End-User
11.5 The Middle East & Africa
11.5.1 The Middle East & Africa Nebulizer Market by country
11.5.2 The Middle East & Africa Nebulizer Market by Type
11.5.3 The Middle East & Africa Nebulizer Market by Application
11.5.4The Middle East & Africa Nebulizer Market by End-User
22.214.171.124 Israel Nebulizer Market by Type
126.96.36.199 Israel Nebulizer Market by End-User
188.8.131.52 Israel Nebulizer Market by Application
11.5.7 UAE184.108.40.206 UAE Nebulizer Market by Type
220.127.116.11 UAE Nebulizer Market by Application
18.104.22.168 UAE Nebulizer Market by End-User
11.5.8 South Africa
22.214.171.124 South Africa Nebulizer Market by Type
126.96.36.199 South Africa Nebulizer Market by Application
188.8.131.52 South Africa Nebulizer Market by End-User
11.5.9 Rest of Middle East & Africa
184.108.40.206 Rest of Middle East & Asia Nebulizer Market by Type
220.127.116.11 Rest of Middle East & Asia Nebulizer Market by Application
18.104.22.168 Rest of Middle East & Asia Nebulizer Market by End-User
11.6 Latin America
11.6.1 Latin America Nebulizer Market by country
11.6.2 Latin America Nebulizer Market by Type
11.6.3 Latin America Nebulizer Market by Application
11.6.4 Latin America Nebulizer Market by End-User
11.6.6 Brazil22.214.171.124 Brazil Nebulizer Market by Type
126.96.36.199 Brazil Africa Nebulizer Market by Application
188.8.131.52Brazil Nebulizer Market by End-User
184.108.40.206 Argentina Nebulizer Market by Type
220.127.116.11 Argentina Nebulizer Market by Application
18.104.22.168 Argentina Nebulizer Market by End-User
11.6.8 Rest of Latin America
22.214.171.124 Rest of Latin America Nebulizer Market by Type
126.96.36.199 Rest of Latin America Nebulizer Market by Application
188.8.131.52 Rest of Latin America Nebulizer Market by End-User
12 Company profile
12.1 Omron Corporation,
12.1.1 Market Overview
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 GE Healthcare
12.2.1 Market Overview
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 Koninklijke Philips N.V.
12.3.1 Market Overview
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 Aire Healthcare
12.4.1 Market Overview
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 Vectura Group Plc.
12.5.1 Market Overview
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 PARI Respiratory Equipment, Inc.
12.6.1 Market Overview
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 AerogenDeVilbiss Healthcare LLC.
12.7.1 Market Overview
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8 Briggs Healthcare.
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 PARI Pharma GmBH.
12.9.1 Market Overview
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10 Beurer GmBH
12.10.1 Market Overview
12.10.4 SWOT Analysis
12.10.5 The SNS View
13. Competitive Landscape
13.1 Competitive Benchmarking
13.2 Market Share analysis
13.3 Recent Developments
14. Use Case and Best Practices
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Cholesterol Test Market was valued at USD 6.35 billion in 2022 and is expected to reach USD 11.58 billion in 2030 and grow at a CAGR of 7.8% over the forecast period of 2023-2030.
The Regenerative medicine market was estimated at USD 55.04 billion in 2022 and is poised to reach at 177.9 billion in 2030 anticipated to expand at a compound annual growth rate approx. CAGR of 15.8% for the forecast period of 2023-2030.
The Mammography Workstations Market Size was valued at USD 143.94 million in 2022, and is expected to reach USD 254.82 billion by 2030, and grow at a CAGR of 7.4% over the forecast period 2023-2030.
The Dental Hygiene Devices Market Size was valued at USD 4.51 billion in 2022 and is expected to reach USD 6.72 billion by 2030, and grow at a CAGR of 5.1% over the forecast period 2023-2030.
The Patient Registry Software Market Size was evaluated at USD 1.72 billion in 2022, and is predicted to increase at a CAGR of 11.9% from 2023 to 2030, to reach USD 4.23 billion by 2030.
In 2022, The Alopecia Treatment Market size amounted to USD 8.0 Billion & is estimated to reach USD 16.12 Billion by 2030 and increase at a compound annual growth rate of 9.2% between 2023 and 2030.
Hi! Click one of our member below to chat on Phone